IMMUNOGEN INC·4

Feb 23, 3:20 PM ET

IMMUNOGEN INC 4

4 · IMMUNOGEN INC · Filed Feb 23, 2017

Insider Transaction Report

Form 4
Period: 2017-02-21
Johnston David Brannon
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2017-02-21$2.47/sh+191,750$473,623201,750 total
Footnotes (1)
  • [F1]These shares are restricted stock which vest annually in three equal installments commencing on February 21, 2018.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -